A detailed history of Harbour Investments, Inc. transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Harbour Investments, Inc. holds 50 shares of PCRX stock, worth $883. This represents 0.0% of its overall portfolio holdings.

Number of Shares
50
Previous 30 66.67%
Holding current value
$883
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$11.7 - $28.46 $234 - $569
20 Added 66.67%
50 $0
Q2 2024

Jul 26, 2024

SELL
$25.5 - $31.51 $1,657 - $2,048
-65 Reduced 68.42%
30 $0
Q1 2024

Jul 22, 2024

BUY
$27.7 - $35.48 $2,631 - $3,370
95 New
95 $2,000
Q1 2023

May 15, 2023

BUY
$35.53 - $43.38 $461 - $563
13 New
13 $0
Q4 2021

Feb 16, 2022

SELL
$47.97 - $62.21 $33,339 - $43,235
-695 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$54.64 - $61.3 $54 - $61
1 Added 0.14%
695 $39,000
Q1 2021

Aug 17, 2021

BUY
$59.31 - $78.82 $41,161 - $54,701
694 New
694 $49,000

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $810M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Harbour Investments, Inc. Portfolio

Follow Harbour Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbour Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Harbour Investments, Inc. with notifications on news.